Ascletis Pharma Inc.

Investors

2024

2023

2022

2021

2020

2019

2018

Proposals for General Mandates to Issue Shares and Repurchase Shares, Re-Election of Retiring Directors and Notice of Annual General Meeting
2024-04-26
Annual Report 2023
2024-04-26
Notification Letter to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
2024-04-09
Notification Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
2024-04-09
Voluntary Announcement - Ascletis Announces Strategic Decisions on FXR Agonist ASC42
2024-04-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
2024-04-02
2023 Annual Results
2024-03-25
Voluntary Announcement - Ascletis Announces Poster Presentation of Phase II Study Final Results of FASN Inhibitor ASC40 for Treatment of Acne at 2024 AAD Annual Meeting
2024-03-11
Next Day Disclosure Returns - Others
2024-03-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
2024-03-01

4

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1